Inotuzumab ozogamacin in refractory or 1st or greater relapse of pediatric B-ALL as bridge to cure: A single center experience
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Waitman Aumann, Katherine Lee, Anna Bennett, Stephanie Bernardo, Lois Chukoian, Kathleen Kaspar, Amy Lahey, Kelly MacDonald, Jacqueline Schlesinger, Daniel John Bergsagel, Diana Fridlyand, Frank Keller, Melinda Pauly, Lauren Raney, Himalee Sabnis, Ryan Summers, Sharon Castellino, Tamara Miller
Institutions: Emory University, Children's Healthcare of Atlanta
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7108490445
Cites:
Cited by:
Related to: